FDA grants accelerated approval of Jemperli (dostarlimab-gxly) for dMMR recurrent or advanced solid tumours

17 August 2021 - Second FDA approval of PD-1 antagonist antibody under clinical development for solid tumours in collaboration with GSK. ...

Read more →

Exelixis announces U.S. FDA accepts for priority review the supplemental new drug application for Cabometyx (cabozantinib) for patients with previously treated radioactive iodine refractory differentiated thyroid cancer

5 August 2021 - U.S. Food and Drug Administration assigned a Prescription Drug User Fee Act action date of 4 December ...

Read more →

PHARMAC's handling of funding request for sanitary products labelled 'devious' and 'underhanded'

3 March 2020 - Last August Dr Sarah Donovan from the University of Otago applied to the drug buying agency, ...

Read more →

'There’s no backup': baby formula crisis hits prescription market

26 April 2018 - On Thursday afternoon, Hannah Goland was within hours of running out of food for her newborn ...

Read more →